Inspire HGNS denied as experimental or investigational by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for inspire hgns are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Inspire HGNS as "Experimental" — and Why This Is Appealable

Blue Cross Blue Shield plans sometimes deny Inspire Upper Airway Stimulation (hypoglossal nerve stimulation, HGNS) as "experimental, investigational, or unproven." This denial reason is increasingly difficult to sustain given that Inspire received FDA premarket approval (PMA) as a Class III medical device and has been covered by many major insurers as medically necessary for appropriate candidates. However, individual BCBS plans — because BCBS is a federation of independent licensees, not a single national insurer — maintain their own medical policies, and some local plans have been slower to update their experimental-status designations. The appeal strategy is to establish the weight of clinical and regulatory evidence supporting the device.

## Federal Appeal Framework

ERISA §503 guarantees full-and-fair internal review for employer-sponsored plans. ACA §2719 adds independent external review by a qualified independent organization. The external review window is approximately four months from the final internal denial. An experimental/investigational denial is one of the most common triggers for external review, and external reviewers are required to apply evidence-based standards — not simply defer to the insurer's own policy. This is a significant procedural advantage for patients.

## Your Concrete Appeal Steps

1. Obtain the FDA PMA approval documentation — download the FDA's PMA approval letter and approval order for Inspire HGNS from accessdata.fda.gov. FDA approval is the primary evidence rebutting an "experimental" classification. 2. Obtain your specific BCBS plan's medical policy — request the exact policy number and the criteria used to classify Inspire as experimental. Some BCBS plans have already reclassified it as covered; others have not. Know which policy is governing your denial. 3. Ask your prescriber to address the experimental classification directly — the medical-necessity letter should state that Inspire HGNS has received FDA approval, has an established body of peer-reviewed literature supporting its use in qualified patients, and is recognized by the relevant specialty societies (such as the American Academy of Sleep Medicine and the American Academy of Otolaryngology). 4. File the internal appeal with FDA documentation, your prescriber's letter, and any BCBS national guidance that supports coverage. 5. Request external review immediately upon internal denial — independent reviewers applying objective standards are well-positioned to overturn experimental-status denials for FDA-approved devices.

## Documentation to Gather

• FDA PMA approval letter for Inspire HGNS
• Your prescriber's letter addressing the experimental classification and citing current clinical consensus
• Your sleep study and CPAP-intolerance records (showing you are a qualified candidate)
• BCBS's written policy used to deny the claim (request this if not included in the denial letter)
• Any coverage determination from another BCBS affiliate plan or from another major insurer that covers Inspire for the same indication

## Criteria-Mapping Structure

Address each element of BCBS's experimental-status framework point by point. Most BCBS plans use a multi-factor test (FDA approval status, peer-reviewed evidence, professional society endorsement, coverage by other plans). Obtain the exact language of each factor from the denial letter or policy document, and map your evidence to each factor in a table: BCBS criterion | Your evidence | Source.